🇩🇪 Germany · EU Public Tender
Abschluss eines nicht-exklusiven Rabattvertrages gemäß §§ 130a Abs. 8 bzw. 130c Abs. 1 SGB V zu Beovu(R) (Wirkstoff: Brolucizumab, ATC-Code: S01LA06)
🏛️ IKK classic · 📍 Dresden
1 €
Estimated value
—
Deadline
| Contract type | Supplies |
| CPV | 33600000 |
| Awarded to | Novartis Pharma GmbH |
Full tender details, bidder list, market context and related contracts available below.
Data sourced from TED — the Official Journal of the EU.